FI925518A0 - Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksiInfo
- Publication number
- FI925518A0 FI925518A0 FI925518A FI925518A FI925518A0 FI 925518 A0 FI925518 A0 FI 925518A0 FI 925518 A FI925518 A FI 925518A FI 925518 A FI925518 A FI 925518A FI 925518 A0 FI925518 A0 FI 925518A0
- Authority
- FI
- Finland
- Prior art keywords
- piperidinylalkanoylarylsulfonamide
- derivatives
- preparation
- therapeutically active
- alkanoylarylsulfonamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Tires In General (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53478490A | 1990-06-07 | 1990-06-07 | |
| US53478490 | 1990-06-07 | ||
| US9103323 | 1991-05-15 | ||
| PCT/US1991/003323 WO1991018603A1 (en) | 1990-06-07 | 1991-05-15 | 1-pyperidinyl alkanoylarylsulfonamide derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI925518A0 true FI925518A0 (fi) | 1992-12-04 |
| FI925518A FI925518A (fi) | 1992-12-04 |
| FI98456B FI98456B (fi) | 1997-03-14 |
| FI98456C FI98456C (fi) | 1997-06-25 |
Family
ID=24131528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI925518A FI98456C (fi) | 1990-06-07 | 1992-12-04 | Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0532629B1 (fi) |
| JP (1) | JP3032294B2 (fi) |
| KR (1) | KR100200461B1 (fi) |
| AT (1) | ATE144899T1 (fi) |
| AU (1) | AU650031B2 (fi) |
| CA (1) | CA2084082C (fi) |
| DE (1) | DE69123052T2 (fi) |
| DK (1) | DK0532629T3 (fi) |
| ES (1) | ES2096651T3 (fi) |
| FI (1) | FI98456C (fi) |
| GR (1) | GR3022327T3 (fi) |
| HU (1) | HU214587B (fi) |
| NO (1) | NO179205C (fi) |
| WO (1) | WO1991018603A1 (fi) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000481A1 (en) * | 1993-06-23 | 1995-01-05 | Merrell Dow Pharmaceuticals Inc. | Piperidin-1-yl-2,2-dialkylpropanonearylsulfonamide derivatives |
| EP0661266A1 (en) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituted cyclic amine compounds as 5HT2 antagonists |
| TWI249526B (en) * | 1998-03-13 | 2006-02-21 | Aventis Pharma Inc | Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| US6713627B2 (en) | 1998-03-13 | 2004-03-30 | Aventis Pharmaceuticals Inc. | Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| US6784192B2 (en) | 2000-01-20 | 2004-08-31 | Eisai Co., Ltd. | Piperidine compound and pharmaceutical composition thereof |
| AU2004218115A1 (en) | 2003-03-07 | 2004-09-16 | Astellas Pharma Inc. | Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| JP5400843B2 (ja) * | 2011-09-06 | 2014-01-29 | 本田技研工業株式会社 | 車両構造 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982001873A1 (en) * | 1980-12-05 | 1982-06-10 | Takeda Chemical Industries Ltd | 1-sulfo-2-oxoazetidine derivatives and process for their preparation |
| FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
| PH23283A (en) * | 1986-02-26 | 1989-06-30 | Eisai Co Ltd | Piperidine derivative, pharmaceutical composition containing the same and method of use thereof |
| PH25458A (en) * | 1987-08-24 | 1991-07-01 | Eisai Co Ltd | Piperidine derivatives, therapeutic, preventive agents |
| US5093341A (en) * | 1987-12-17 | 1992-03-03 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl piperidine derivatives useful as antithrombolytic agents |
| US5064838A (en) * | 1988-01-21 | 1991-11-12 | Merrell Dow Pharmaceuticals | 1,4-disubstituted-piperidinyl compounds as pain relievers |
| NZ236501A (en) * | 1989-12-21 | 1992-12-23 | Merrell Dow Pharma | Piperidine derivatives and antithrombotic compositions |
-
1991
- 1991-05-15 WO PCT/US1991/003323 patent/WO1991018603A1/en active IP Right Grant
- 1991-05-15 DK DK91911167.4T patent/DK0532629T3/da active
- 1991-05-15 ES ES91911167T patent/ES2096651T3/es not_active Expired - Lifetime
- 1991-05-15 CA CA002084082A patent/CA2084082C/en not_active Expired - Lifetime
- 1991-05-15 EP EP91911167A patent/EP0532629B1/en not_active Expired - Lifetime
- 1991-05-15 HU HU9203856A patent/HU214587B/hu not_active IP Right Cessation
- 1991-05-15 AT AT91911167T patent/ATE144899T1/de not_active IP Right Cessation
- 1991-05-15 JP JP3510423A patent/JP3032294B2/ja not_active Expired - Lifetime
- 1991-05-15 DE DE69123052T patent/DE69123052T2/de not_active Expired - Lifetime
- 1991-05-15 AU AU79922/91A patent/AU650031B2/en not_active Expired
-
1992
- 1992-12-04 NO NO924694A patent/NO179205C/no not_active IP Right Cessation
- 1992-12-04 FI FI925518A patent/FI98456C/fi active
- 1992-12-05 KR KR1019920703112A patent/KR100200461B1/ko not_active IP Right Cessation
-
1997
- 1997-01-22 GR GR960403347T patent/GR3022327T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT64517A (en) | 1994-01-28 |
| FI98456B (fi) | 1997-03-14 |
| WO1991018603A1 (en) | 1991-12-12 |
| FI98456C (fi) | 1997-06-25 |
| DE69123052T2 (de) | 1997-03-06 |
| NO924694L (no) | 1992-12-04 |
| EP0532629A4 (fi) | 1994-03-09 |
| DE69123052D1 (de) | 1996-12-12 |
| JPH06501242A (ja) | 1994-02-10 |
| KR100200461B1 (ko) | 1999-06-15 |
| EP0532629B1 (en) | 1996-11-06 |
| NO179205C (no) | 1996-08-28 |
| NO924694D0 (no) | 1992-12-04 |
| CA2084082A1 (en) | 1991-12-08 |
| EP0532629A1 (en) | 1993-03-24 |
| JP3032294B2 (ja) | 2000-04-10 |
| AU7992291A (en) | 1991-12-31 |
| KR930700441A (ko) | 1993-03-15 |
| HU9203856D0 (en) | 1993-04-28 |
| CA2084082C (en) | 2002-03-19 |
| ATE144899T1 (de) | 1996-11-15 |
| FI925518A (fi) | 1992-12-04 |
| GR3022327T3 (en) | 1997-04-30 |
| DK0532629T3 (da) | 1996-11-25 |
| NO179205B (no) | 1996-05-20 |
| ES2096651T3 (es) | 1997-03-16 |
| AU650031B2 (en) | 1994-06-09 |
| HU214587B (hu) | 1998-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO177139C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-amidoindolylderivater | |
| FI881103A0 (fi) | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi | |
| FI91152B (fi) | Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| NO914667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
| NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
| NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO175478C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater | |
| FI930723A0 (fi) | Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi | |
| NO175528C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater | |
| NO163331C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer. | |
| FI98456B (fi) | Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi | |
| FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| FI100799B (fi) | Menetelmä terapeuttisesti aktiivisten tetraliinijohdannaisten valmista miseksi | |
| NO173606C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater | |
| FI97388B (fi) | Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi | |
| NO175780C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte dibenzofuraner | |
| NO177710C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive slektede analoger | |
| FI97885B (fi) | Menetelmä terapeuttisesti aktiivisten nojirimysiinijohdannaisten valmistamiseksi | |
| NO174958C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tetralinderivater | |
| NO961910L (no) | Fremgangsmåte for fremstilling av terapeutisk aktive polyamider | |
| NO302577B1 (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive dekapeptider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| PC | Transfer of assignment of patent |
Owner name: AVENTIS INC. Free format text: AVENTIS INC. |
|
| PC | Transfer of assignment of patent |
Owner name: AVENTISUB II INC. Free format text: AVENTISUB II INC. |